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Velocity (PSV) decreased from 40.97 m/s to 0.900.14 m/s. The 6- and 12-month PSV
values after DEB were significantly lower as compared to those obtained after CAS at the
same time intervals(Figure).
Conclusions: DEB treatment of ISR after CAS is feasible. Initial results show safety and
effectiveness.
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Background: After embolic protected CAS, new cerebral ischemic lesions have been
reported in up to 70 % of patients. There impact on long-term prognosis after CAS is
unknown. Aim of the study was to evaluate the impact of new asymptomatic cerebral
ischemic lesions, found in diffusion weighted magnetic resonance imaging (DWMRI)
after embolic protected carotid artery stenting (CAS), on long-term prognosis.
Methods: 837 consecutive patients who had an embolic protected CAS without
peri-procedural complications and had a DWMRI before and 24 hours after the procedure
were included. Cox Regression analyses were performed to identify independent risk
factors for long-term major adverse cerebral and cardiovascular events (MACCE)
including patient-, lesion-, and procedural characteristics as well as the result of the
DWMRI.
Results: The follow-up rate was 91 %. At a mean follow up of 779.5  535.8 days.
MACCE occurred in 6.04 % of the patients. Diabetes was the only significant independent
predictor for MACCE. Asymptomatic ischemic cerebral lesions after CAS were not
associated with MACCE during long-term FU.
Conclusions: In patients who underwent uncomplicated embolic protected CAS,only
diabetes was predictive for long-term MACCE, whereas asymptomatic ischemic embolic
events during CAS had no impact on long-term outcome.
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Background: Internal carotid artery stenosis (CS) degree is a poor marker of symptom
risk, and plaque morphology might play an important role. IVUS offers high-resolution
(axial0.12mm for 20MHz transducer) plaque imaging; nevertheless, phenotypic virtual
histology (VH-IVUS) carotid plaque classification was shown to be prone to between-
center and between-observer image interpretation variability.
Methods: We developed and implemented a novel Q-IVUS software-based algorithm for
detailed quantitative CS plaque VH-IVUS analysis to supplement the conventional
phenotypic plaque classification. Following inter-transducer and inter-observer reproduc-
ibility validation (n21, separate communication), we employed the QVH-IVUS ’peak’
algorithm (including standard - total component value per plaque cross-sectional area, PA;
and novel parameters - eg, minimal fibrous cap thickness, confluent necrotic core area,
thickness and arc) to evaluate 222 index CS lesions in 222 consecutive patients (age
47–83y, 62.6% men, 68.9% with h/o CS-attributable symptoms, S) presenting with
CS50% in the context of potential revascularization. Use of EPD for CS imaging (67%)
was left to operator (filters 
 ¾, proximal 
 1⁄4).
Results: Table; values are peakSEM per PA; abstract p values are for Total Asympt vs.
Total Sympt CS lesions. MLAminimal lumen area, ASarea stenosis, PBplaque
burden, FCfibrous cap, NCnecrotic core, FFfibro-fatty, Cadense calcium,
FTfibrotic).
Conclusions: QVH-IVUS ’peak’ image analysis of the carotid atherosclerotic plaque
revealed significant inter-group differences in novel QVH-IVUS plaque parameters,
including lower minimal FC thickness and higher confluent NC-area, -thickness and -arc,
and higher peak confluent Ca-area in S lesions. Further work will test the role of
QVH-IVUS ’peak’ image analysis algorithm in identifying the asymptomatic CS lesions
at risk of symptomatic transformation.
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Background: Chronic cerebrospinal venous insufficiency (CCSVI) characterized by
stenoses or obstructions of the internal jugular veins (IJV) and/or azygos vein (AZY), has
been reported to be associated with multiple sclerosis (MS). However, such association is
a matter of debate. The aim of our retrospective analysis was to determine the relationship
between the extent of extracranial venous pathology and clinical severity of MS.
Methods: We analyzed 50 consecutive patients (pts) with relapsing-remitting (32 pts)
and secondary progressive (18 pts) clinical course of MS (age 3810 years, M:F15:35)
scheduled for duplex ultrasound (DUS), invasive phlebography, and eventual endovas-
cular procedure of IJV and/or AZY. The extent of stenotic/obstructive process of IJV, and
AZY, or IJV reflux, were graded by combination of invasive phlebography and duplex
ultrasound as negative (group A), unilateral/focal stenosis/regurgitation (group B), or
bilateral/multifocal stenoses/regurgitation (group C). The clinical severity of MS was
evaluated by expanded disability disease scoring (EDSS). The study was approved by the
local scientific and ethical committee.
Results: Out of 50 analyzed pts (mean EDSS 3.72.4) there were 10 pts with negative
DUS and venous phlebography pathology (20%), 16 pts with unilateral/focal venous
pathology (32%), and 24 pts with bilateral/multifocal pathology (48%). The 20 cases were
treated by balloon angioplasty alone, whereas the stenting of at least one vein was required
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in 14 pts. Importantly, there was significant difference in MS clinical severity of group A
versus group B (EDSS 1.81.3 vs 3.02.2, p0.05), as well as compare to group C
(EDSS group B vs group C 3.02.2 vs 5.02.2, p0.005). Similarly, there was
significant difference in MS duration in group A versus group C (43 years versus 95
years, p0.005).
Conclusions: The clinical severity of multiple sclerosis as well as duration of disease
seems to be associated with the extent of pathological venous drainage of the central
nervous system. To answer the question if CCSVI is only the accompanying secondary
process, or the underlying condition of MS, the blinded randomized studies are needed.
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Background: Various techniques are used for the treatment of internal carotid artery
stenosis, consisting of predilatation of the lesion, self-expanding or balloon-expanded
stents with or without protective devices. The aim of our study was to evaluate the
feasibility, safety, and efficacy of four different interventional techniques.
Methods: In a series of 1075 consecutive patients (346 female/729 male, mean age 70
years) carotid artery stenting (CAS) was performed. Indications for CAS were either
symptomatic patients with a stenosis  60% or asymptomatic stenoses  80%. Adverse
events were defined as death, stroke (24 hours), PRIND ( 72 hours). We evaluated
four different techniques that were: 1. predilatation before stenting with (PBS-with) and 2.
without cerebral protection (PBS-noPro), and 3. stenting without predilatation (NPBS-
withPro) with and 4. without cerebral protection (NPBS-noPro).
Results: Technical success was achieved in 491 NPBS-withPro patients (99%) and in
299 NPBS-noPro (94%). In patients with predilatation, technical success could be
achieved in 114 PBS-withPro (99%) and in all (100%) PBS-noPro patients. The groups
with the highest risk of procedural adverse events were PBS-noPro with 4.8% and
NPBS–noPro with 4.7%. Adverse events occured in the NPBS-withPro patients in 2%,
and in the PBS-with patients in 0.8%. However, these differences did not reach statistical
significance (NPBS-withPro vs. NPBS-noPro  ns, NPBS-withPro vs. PBS-withPro 
ns, NPBS-withPro vs. PBS-noPro  ns, NPBS-noPro vs. PBS-withPro  ns, NPBS-
noPro vs. PBS-noPro  ns, PBS-withPro vs. PBS-noPro  ns). The only significant
difference in the risk of procedural events was found for patients with, versus patients
without the use of protective devices (NPBS-withPro	 PBS-withPro (n612, 12 adverse
events, 1,7%) vs. NPBS-noPro 	 PBS-noPro (n463, 19 adverse events, 4.1%, p 
0.05).
Conclusions: The risk of adverse events (stroke/death) during CAS is associated with the
use of cerebral protection rather than the use of predilatation or not.
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Background: To study early and 1-year outcomes of carotid artery stenting (CAS) and
carotid endaterectomy (CEA) in patient with medical comorbidities according to Euro-
score risk evaluation model.
Methods: We retrospectively reviewed 312 patients who were treated for symptomatic
carotid stenosis between 2002 and 2012 (142 CASs and 170 carotid endarterectomies
CEAs)
Results: Patients undergoing CEA were older than CAS (78 years vs. 70 years, P 
0.001). Embolic protection devices were used in 98.6% of cases. Depending on
comorbidities all patient were divided in two groups: EuroSCORE  20 (n – 181) and
EuroSCORE  20 (n – 131). In EuroSCORE  20 group CAS was performed in 75
patients, CEA – in 106 patients. The 30-days stroke rate did not differ between subgroups
(2.7% in CAS vs. 1.9% CEA, p 0.05). The 1-year freedom from stroke were 93.4% in
CAS subgroup and 94.3% in CEA subgroup (p  0.05). There was no difference in the
all-cause death rate (stroke-related, coronary, other) at 1-year follow-up (2.7% in CAS
subgroup vs 4.9%, p  0.05). In EuroSCORE  20 group CAS was performed in 73
patients, CEA – in 58 patients. There was no difference in the incidence of 30-days stroke
(2.8% in CAS vs. 1.7% CEA, p 0.05). The 1-year freedom from stroke were 93.2% in
CAS subgroup and 94.9% in CEA subgroup (p  0.05). The all-cause death rate among
CAS patients was lower (1.4%) compared to CEA patients (12%, p 0.044). Univariate
analysis in patients undergoing CAS showed that and age  70 years was related with
postprocedural neurological complications (p  0.046). However, age was not indepen-
dent risk factors on multivariate analysis
Conclusions: In the low-risk patients (EuroSCORE  20) the rates of peri-procedural,
long-term neurological complications and all-cause death rate did not differ between CAS
and CEA subgroups. In high-risk patients (EuroSCORE  20) there was no significant
difference in the incidence of peri-procedural and long-term neurological complications
between subgroups, but patients after CEA are at higher risk for any-cause related death.
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Background: Carotid artery stenting (CAS) is viable alternative to carotid endarterec-
tomy (CEA). Femoral access for CAS may be problematic due to peripheral vascular
disease, anatomical variations of the aortic arch, and access site complications. The
primary endpoint of this study was to evaluate the right transradial approach (TRA) for
CAS.
Methods: A retrospective analysis of all 420 pts that underwent TRA CAS at two centers
was performed. Demographics, the technique used to deploy the sheath in the common
carotid, procedural details, results, and complications were evaluated.
Results: CAS was attempted from TRA in 420 pts (mean age 69, 72% male).
Comorbidities increasing the risk of CEA were present in 334(79%) and 213(51%) were
symptomatic. CAS was successful in 395/420 (94%) pts; 239/254 (94%) right CA, 15/17
(88%) bovine left CA, 181/199 (91%) left CA. The specific technique varied with the
anatomy. The initial diagnostic catheter for RCA was Simmons 1 (25%) or Simmons 2
(more acute angle) (52%); for bovine left CA an Amplatz R2 (36%) or Simmons (more
vertical takeoff) (29%); and for non-bovine left CA a wire-braided Simmons 2 (77%). The
diagnostic catheter was then exchanged for a 5F (26%) or 6F (69%) sheath or 7F guide
(5%) over an .035 standard (4%) or Amplatz superstiff guidewire (73%), or Glidewire
(23%). In more recent cases, a one-step method advancing a TAD II guidewire directly
into the external for shuttle sheath exchange was utilized (6%). Seven different carotid
artery stents (50% Xact) and 7 different distal embolic protection devices were used.
Adverse events included 2 major strokes (0.48%) one of whom died, 4 minor strokes
(0.96%), and no myocardial infarction at 30 days. No bleeding complications occurred
although 23 (6%) of patients had asymptomatic post-procedure radial occlusion. Inade-
quate catheter support at the origin of the CCA was the technical cause of failure in the
unsuccessful cases that were completed from femoral access as part of the same
procedure.
Conclusions: The transradial approach is save, consistent and efficient technique for
CAS in the presence of factors that increase the risk or difficulty of femoral access.
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Background: Cerebral ischemia secondary to severe stenosis of the major arch vessels
is a well known phenomenon in Takayasu arteritis. Significant obstruction of one or more
arteries supplying the brain can lead to ischemic CVA, syncope, transient ischemic attack,
or visual impairment. In the past 5 years we had 18 patients with Takayasu arteritis with
such symptoms in whom 22 lesions were subjected to angioplasty with stenting.
Methods: During the period April, 2007 to march, 2012, total 24 patients that were
diagnosed to have Takayasu arteritis showed symptoms of cerebral ischemia. Of them 18
patients (22 lesions in supraaortic arteries-carotid, vertebral or brachiocephalic) with age
ranging from 24 yr to 48 yr (mean age 27.6  1.15 years) underwent angioplasty with
stenting to one or more lesions. The procedural details and acute and follow-up data of
these 18 cases was analysed in this study.
Results: Angioplasty was attempted on 22 lesions (carotid-10, vertebral-6, and
brachiocephalic-6). The procedure was successfully completed in 20 out of 22 lesions.
Bare-metal stents were deployed in all 20 cases (rapid exchange system- 12 and
over-the-wire system-8; balloon-expandable-8 and self-expandable-12).The wire could
not cross 2 lesions with total occlusion of brachiocephalic arteries. Two had suboptimal
result with 20% residual stenosis. One case of carotid angioplasty had TIA and another
had seizures after 3 hours of the procedure. In one case there was femoral pseudoaneu-
rysm which could be managed conservatively. On follow-up there was marked symp-
tomatic relief in 17 of the 18 cases (94.4%). Only 12 cases came for follow-up angiograms
at a mean period of 7.45  1.25 months and 3 (25%) had restenosis.
Conclusions: Angioplasty and stenting of the significant lesions in supra-aortic
vessels in symptomatic patients with Takayasu arteritis showed acceptable acute
success. The symptomatic relief was well maintained most of the patients at
follow-up.
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